These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 17521732)
1. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission. Takada E; Okahira S; Sasai M; Funami K; Seya T; Matsumoto M Mol Immunol; 2007 Jul; 44(15):3633-40. PubMed ID: 17521732 [TBL] [Abstract][Full Text] [Related]
2. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway. Sasai M; Tatematsu M; Oshiumi H; Funami K; Matsumoto M; Hatakeyama S; Seya T Mol Immunol; 2010 Mar; 47(6):1283-91. PubMed ID: 20047764 [TBL] [Abstract][Full Text] [Related]
3. The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling. Funami K; Matsumoto M; Oshiumi H; Akazawa T; Yamamoto A; Seya T Int Immunol; 2004 Aug; 16(8):1143-54. PubMed ID: 15226270 [TBL] [Abstract][Full Text] [Related]
4. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis. Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355 [TBL] [Abstract][Full Text] [Related]
5. N-terminal binding site in the human toll-like receptor 3 ectodomain. Watanabe T; Tokisue T; Tsujita T; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K Nucleic Acids Symp Ser (Oxf); 2007; (51):405-6. PubMed ID: 18029758 [TBL] [Abstract][Full Text] [Related]
6. Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing. Seya T; Matsumoto M; Ebihara T; Oshiumi H Immunol Rev; 2009 Jan; 227(1):44-53. PubMed ID: 19120474 [TBL] [Abstract][Full Text] [Related]
8. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction. Takaki H; Oshiumi H; Sasai M; Kawanishi T; Matsumoto M; Seya T Eur J Immunol; 2009 Dec; 39(12):3469-76. PubMed ID: 19795416 [TBL] [Abstract][Full Text] [Related]
9. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction. Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880 [TBL] [Abstract][Full Text] [Related]
10. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production. Chiron D; Pellat-Deceunynck C; Amiot M; Bataille R; Jego G J Immunol; 2009 Apr; 182(7):4471-8. PubMed ID: 19299748 [TBL] [Abstract][Full Text] [Related]
11. Isolation of RNA aptamers against human Toll-like receptor 3 ectodomain. Watanabe T; Ito K; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K Nucleic Acids Symp Ser (Oxf); 2006; (50):251-2. PubMed ID: 17150912 [TBL] [Abstract][Full Text] [Related]
12. Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction. Shingai M; Azuma M; Ebihara T; Sasai M; Funami K; Ayata M; Ogura H; Tsutsumi H; Matsumoto M; Seya T Int Immunol; 2008 Sep; 20(9):1169-80. PubMed ID: 18611945 [TBL] [Abstract][Full Text] [Related]
13. The molecular structure of the TLR3 extracellular domain. Bell JK; Botos I; Hall PR; Askins J; Shiloach J; Davies DR; Segal DM J Endotoxin Res; 2006; 12(6):375-8. PubMed ID: 17254392 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the interaction between human TLR3 ectodomain and nucleic acids. Fukuda K; Tsujita T; Matsumoto M; Seya T; Sakiyama H; Nishikawa F; Nishikawa S; Hasegawa T Nucleic Acids Symp Ser (Oxf); 2006; (50):249-50. PubMed ID: 17150911 [TBL] [Abstract][Full Text] [Related]
15. Structural insights of rohu TLR3, its binding site analysis with fish reovirus dsRNA, poly I:C and zebrafish TRIF. Sahoo BR; Basu M; Swain B; Maharana J; Dikhit MR; Jayasankar P; Samanta M Int J Biol Macromol; 2012 Nov; 51(4):531-43. PubMed ID: 22705475 [TBL] [Abstract][Full Text] [Related]
16. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway. Jiang Q; Wei H; Tian Z BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340 [TBL] [Abstract][Full Text] [Related]
17. TLR3: interferon induction by double-stranded RNA including poly(I:C). Matsumoto M; Seya T Adv Drug Deliv Rev; 2008 Apr; 60(7):805-12. PubMed ID: 18262679 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells. Nakada E; Walley KR; Nakada T; Hu Y; von Dadelszen P; Boyd JH Placenta; 2009 Sep; 30(9):774-9. PubMed ID: 19631980 [TBL] [Abstract][Full Text] [Related]
19. Down modulation of human TLR3 function by a monoclonal antibody. Duffy KE; Lamb RJ; San Mateo LR; Jordan JL; Canziani G; Brigham-Burke M; Korteweg J; Cunningham M; Beck HS; Carton J; Giles-Komar J; Duchala C; Sarisky RT; Mbow ML Cell Immunol; 2007 Aug; 248(2):103-14. PubMed ID: 18048020 [TBL] [Abstract][Full Text] [Related]
20. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. Peter ME; Kubarenko AV; Weber AN; Dalpke AH J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]